Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Diabetologia|April 6, 2002
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy menH Agersø, L B Jensen, B Elbrønd, et al.Journal of Thrombosis and Haemostasis : JTH|March 1, 2016
Canine models of inherited bleeding disorders in the development of coagulation assays, novel protein replacement and gene therapiesT C Nichols, C Hough, H Agersø, et al.Journal of Pharmacological and Toxicological Methods|October 3, 1999
Plasma concentration of hGH and anti-hGH antibodies after subcutaneous administration of hGH for 3 weeks to immunosuppressed pigsH Agersø, M Wilken, J Drustrup, et al.Journal of Thrombosis and Haemostasis : JTH|December 1, 2010
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patientsH Agersø, D F Brophy, H Pelzer, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 8, 2011
Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dogT Knudsen, A T Kristensen, T C Nichols, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 21, 2011
Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogsD M Karpf, M Kjalke, L Thim, et al.Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 18, 2000
The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteersM Zdravkovic, B Søgaard, L Ynddal, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 21, 2012
Pharmacokinetics and pharmacodynamics of turoctocog alfa and N8-GP in haemophilia A dogsH Agersø, H R Stennicke, H Pelzer, et al.Journal of Medicinal Chemistry|May 5, 2000
Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administrationL B Knudsen, P F Nielsen, P O Huusfeldt, et al.British Journal of Anaesthesia|October 8, 2009
Effects of a recombinant FVIIa analogue, NN1731, on blood loss and survival after liver trauma in the pigM Zaar, N H Secher, P I Johansson, et al.Pageof 3